S(+)-Ibuprofen Effects on Asprin Treated Volunteers

• Status: Completed
• Trial end date: 2007-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this clinical trial is to determine whether S(+)-ibuprofen affect the platelet inhibition under steady state acetylsalicylic acid conditions.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Gebro Pharma GmbH
• Treatments: Ibuprofen

Criteria

Inclusion Criteria:

• Healthy caucasian volunteer

• Must be able to swallow tablets

Exclusion Criteria:

• Underlying diseases

• Ulcus pepticum in history

• Abuse of alcoholic beverages (40g/d)

• Hypersensitivity to investigational medicinal products